OTR3 - Publications

RGTA® technology’s breakthrough potential is supported
by more than 100 preclinical and clinical publications

Main publications and articles on RGTA® :

All

Graft

Neurology

Musculoskeletal and Locomotor

Imaging

Cardiovascular

Gastro-Intestinal

Dermatology

Ophtalmology

Other

Oncology

Stem Cells

Dental and Oral

Urology and Gynecology

RGTA technology

CACICOL

Cacipliq 20

A Retrospective Self-Controlled Study Evaluating the Prophylactic Effects of CACIPLIQ20 on Postsurgical Scars

OTR3 is proud to share a recent publication in the “Aesthetic Surgery Journal Open Forum” from the Oxford University Press concerning “a retrospective self-controlled study evaluating the Prophylactic Effects of our Medical Device Cacipliq 20 on Postsurgical scars.

A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis

Barbosa et al.

Effect of a Matrix Therapy Agent on Corneal Epithelial Healing After Standard Collagen Cross-linking in Patients With Keratoconus: A Randomized Clinical Trial

Bata et al. JAMA Ophthalmol 2016 1;134(10):1169-1176. doi: 10.1001/jamaophthalmol.2016.3019.

A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle

Desgranges et al. FASEB J . 1999;13(6):761-6. doi: 10.1096/fasebj.13.6.761.

A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers

Escartin et al FASEB J 2003 ;17(6):644-51. doi: 10.1096/fj.02-0708com.

A heparan sulfate-based matrix therapy reduces brain damage and enhances functional recovery following stroke

Khelif, Y. et al Theranostics . 2018 ;8(21):5814-5827. doi: 10.7150/thno.28252

Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-beta1.

Mestries, P. et al.

Diabetes-Impaired Wound Healing Is Improved by Matrix Therapy With Heparan Sulfate Glycosaminoglycan Mimetic OTR4120 in Rats.

Miao Tong, et al

RGTA(R) or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients

Barritault et al.

Organes Tissus Regeneration Reparation Remplacement

Legal Notices and General Conditions of Use

ADDRESS

4, rue Française
75001 Paris, France

CONTACT

+33 (0)1 83 64 23 00